Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors
|
|
- Tyler Booker
- 5 years ago
- Views:
Transcription
1 Conflict of Interest Statements for The American Journal of Clinical Nutrition Editors David B Allison Dr. Allison has received personal payments or promises for same from: American Society for Nutrition; Biofortis; Frontiers Publishing; IKEA; Indiana University; Laura and John Arnold Foundation; Law Offices of Ronald Marron; MD Anderson Cancer Center; National Academy of Sciences; National Institutes of Health (NIH); Nestlé; Paul Hastings, LLP; Texas A&M University; The Obesity Society; Tomasik, Kotin & Kasserman LLC; University of Miami. Dr. Allison receives editorial honoraria from the American Society for Nutrition and the Obesity Society. Donations to a foundation have been made on his behalf by the Northarvest Bean Growers Association and the United Soy Bean Board. Dr. Allison is an unpaid member of the International Life Sciences Institute North America Board of Trustees. Dr. Allison s institution, Indiana University, has received funds to support his research or educational activities from: USDA; NIH; US National Science Foundation; Alliance for Potato Research and Education; Dairy Management Institute; Herbalife; Laura and John Arnold Foundation. Arne Astrup Dr. Astrup receives payment as Associate Editor of The American Journal of Clinical Nutrition and as a member of the Editorial Committee of Annual Review of Nutrition. Dr. Astrup is advisor to or a member of advisory boards for a number of food and pharmaceutical producers: Basic Research, United States; Beachbody, United States; BioCare Copenhagen, Denmark; Crossfit, United States; Dutch Beer Institute, Netherlands; Feast Kitchen A/S, Denmark; Gelesis, United States; Groupe Éthique et Santé, France; McCain Foods Limited, United States; Nestlé Research Centre, Switzerland; Novo Nordisk, Denmark; Pfizer, Germany; Saniona, Denmark; Sanofi- Aventis, Germany; S-Biotek, Denmark; Scandinavian Airlines System, Denmark; TetraPak, Sweden; Weight Watchers, United States; Zaluvida, Switzerland. Dr. Astrup does not own stock in, or have other ownership interests in, any of the companies to which he provides scientific advice, or in any nutrition company other than those companies whose stock
2 is held by various mutual fund retirement accounts. Dr. Astrup s recent research at the University of Copenhagen, Denmark, has received funding via unrestricted grants from or contracts with DC-Ingredients, Denmark; Danish Dairy Foundation; Global Dairy Platform; and Gelesis AS, United States. Dr. Astrup is the recipient of honoraria as speaker for a wide range of Danish and international concerns and receives royalties from textbooks and popular diet and cookery books. Dr. Astrup is co-inventor of a number of patents, including Methods of inducing weight loss, treating obesity and preventing weight gain (licensee Gelesis, United States) and Biomarkers for predicting degree of weight loss (licensee Nestec SA, Switzerland), owned by the University of Copenhagen, in accordance with Danish law. Dr. Astrup is co-founder and co-owner of the University of Copenhagen spin-out companies Mobile Fitness A/S, Personalized Weight Management Research Consortium ApS (Gluco-diet.dk), and Flaxslim ApS, where he is also member of the board. Dr. Astrup is not an advocate or activist for specific diets and is not strongly committed to any specific diet, e.g., veganism, Atkins diet, glutenfree diet, high animal protein diet, or dietary supplements. Dennis M Bier Dr. Bier accepts no honorarium for the work he performs as Editor-in-Chief of The American Journal of Clinical Nutrition. Dr. Bier is an advisor to the International Council on Amino Acid Science, whose members include companies that produce and market amino acids for medical, biological, and industrial purposes. Dr. Bier provides the Council with advice on scientific priorities, assistance in organizing scientific symposia on amino acids, and evaluation of competitive applications for research funding. Other than reimbursement for travel expenses, he accepts no compensation for his advisory role. In the past year, Dr. Bier has consulted for, and received honoraria from, Mallinckrodt Pharmaceuticals; Novartis Pharmaceuticals; Nestlé SA; Ajinomoto Co., Inc.; Soremartec Italia S.r.l.; the CrossFit Foundation; Intertek Scientific and Regulatory Consultancy Services; Nutritional Growth Solutions; the Dairy Management Institute;
3 and the Lorenzini Foundation. The majority of Dr. Bier s consulting fees are donated to charity. Dr. Bier does not own stock in, or have other ownership interests in, any of the companies to which he provides scientific advice or in any nutrition company other than those companies whose stock is held by various mutual fund retirement accounts. Paul M Coates Dr. Coates does not receive an honorarium from the American Society for Nutrition for his duties as Associate Editor. Naomi K Fukagawa Dr. Fukagawa receives an honorarium from the American Society for Nutrition for her duties as Associate Editor. Dr. Fukagawa serves as Director of the USDA Beltsville Human Nutrition Center. Dr. Fukagawa is the Editor-in-Chief of Nutrition Reviews. David M Klurfeld Dr. Klurfeld does not receive an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Klurfeld is a nutrition consultant to Dyets, Inc, a manufacturer of diets for laboratory animals. Dr. Klurfeld is a member of the American Council on Science and Health Board of Scientific and Policy Advisors whose function is to provide advice and review of statements developed by the organization. This is a noncompensated position. Simin Liu Dr. Liu reports consulting payments and honoraria or promises of the same for scientific presentations or reviews at numerous venues, including but not limited to Barilla, Johns Hopkins University, Fred Hutchinson Cancer Center, Harvard University, University of Buffalo, GuangDong General Hospital and Academy of Medical Sciences, and the National Institutes of Health. He is also a member of the Data Safety and Monitoring Board for a trial of pulmonary hypertension in diabetes patients at Massachusetts General Hospital. He receives royalties from UpToDate. Dr.
4 Liu receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Liu is listed as the lead inventor on U.S. Application Serial No. or PCT International Application No. PCT/US2009/ filed on November 16, 2009 by UCLA concerning METHODS AND COMPOSITIONS FOR PREDICTING A SUBJECT'S SUSCEPTIBILITY TO AND RISK OF DEVELOPING TYPE 2 DIABETES. Mark J Manary Dr. Manary is the Director of Project Peanut Butter, a not-for-profit focusing on improving the treatment of malnutrition as well as the production of appropriate, nutrient-dense foods. His present research activities are funded primarily by Children s Investment Fund Foundation and USAID Feed the Future program. Dr. Manary has accepted contributions of food ingredients necessary for his research work from Arla Dairy Ingredients. Dr. Manary has provided technical advice in areas of his competence on an ad-hoc basis. He does not own personal stock except for investment funds related to his pension that are not under his direct control. Dr. Manary is a member of the WHO technical expert committee on nutrition, which reviews evidence and writes draft guidelines for treatment and prevention of malnutrition worldwide. Dr. Manary does not hold or have pending patent applications related or unrelated to his research activities. Dr. Manary has spoken at meetings and conferences at the invitation of organizations representing the peanut and dairy industries, usually once a year; they have paid his travel expenses, but he has not accepted personal payments or honoraria from these organizations. Dr. Manary receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Richard Mattes Dr. Mattes receives an honorarium from the American Society for Nutrition for his duties as Associate Editor. Dr. Mattes has received travel expenses and/or honoraria for serving on scientific advisory bodies forconagra and the Grain Food Foundation and planning committees for the American Society for Nutrition, Academy for Nutrition and Dietetics, and Institute for Food Technologists. Dr. Mattes has received
5 research support and/or travel expenses from the Almond Board of California, California Walnut Commission, and Ajinomoto Co. Inc. Dr. Mattes has received travel expenses and/or honoraria for speaking at various professional meetings. Sue A Shapses Dr. Shapses receives an honorarium from the American Society for Nutrition for her duties as Associate Editor; the honorarium is used for scholarship and research purposes. Dr. Shapses, as an investigator, received research funds or consulting fees from Merck, Inc., Omni Active Tech., and Bayer, Inc. Dr. Shapses received honorarium fees and/or travel reimbursement from Johns Hopkins University, Columbia University, Wake Forest School of Medicine, and the American College of Sports Medicine. Dr. Shapses receives honorarium fees and/or travel reimbursement for consulting duties at NASA and NIH.
SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry
Introduction SMA Europe Code of Practice on Relationships with the Pharmaceutical Industry SMA Europe is an umbrella body of national Spinal Muscular Atrophy patient representative and research organisations
More informationSeptember 18, 2017 Special Called Meeting of the U. T. System Board of Regents - Meeting of the Board
AGENDA SPECIAL CALLED TELEPHONE MEETING of THE UNIVERSITY OF TEXAS SYSTEM BOARD OF REGENTS September 18, 2017 Austin, Texas Page CONVENE THE BOARD IN OPEN SESSION TO RECESS TO EXECUTIVE SESSION PURSUANT
More informationPurpose of the summary
Summary of Expertise, Experience, and Affiliations and Interests Scientific Advisory Committee on Sciences and Clinical Pharmacology (SAC-PSCP) Purpose of the summary The following table summarizes the
More informationYevo Scientific Advisory Board
TM Yevo Scientific Advisory Board Dr. Stacey J. Bell Head of the Yevo Scientific Advisory Board Dr. Stacey Bell has been a nutritional consultant from 2008 to 2014, when she joined Yevo International.
More informationManaging Conflict of Interest
Managing Conflict of Interest The Challenge of Pharmaceutical Company Marketing to Medical Professionalism David J. Rothman, Ph.D. Bernard Schoenberg Professor of Social Medicine Columbia College of Physicians
More informationBiotech Concerto #6 Investment Process December 2008
Biotech Concerto #6 Investment Process December 2008 Index Biotech Investment Characteristics Investment Policy Investment Team Scientific Advisory Board Deal Flow Attrition Rate From Screening to Decision
More informationOther appointments: Chairman of the Advisory Committee of Zentiva Group, Industrial Advisor EQT.
Executive Committee Guido Oelkers Chief Executive Officer Born 1965. Employed since 2017. PhD in Strategic Management, University of South Australia, Master of Economics, South Bank University, London,
More informationParenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy)
Parenteral Nutrition Down Under Inc. (PNDU) Working with Pharmaceutical Companies Policy (Policy) BACKGROUND (Reason or Purpose) The purpose of this Policy is to provide clear principles and guidance about
More informationPolicy for CCG Engagement with the Pharmaceutical Industry
Policy for CCG Engagement with the Pharmaceutical Industry UNIQUE REFERENCE NUMBER: CD/MM/066/V1 DOCUMENT STATUS: DATE ISSUED: October 2014 DATE TO BE REVIEWED: October 2016 Approved by Clinical Development
More informationForm FI. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007.
Form 51-102FI SERNOVA CORP. Management s Discussion and Analysis of Results of Operations and Financial condition for the six months ended April 30, 2007. The following discussion and analysis should be
More informationCommercialization Workshop Series Commercialization Pathways. April 2, 2015
Commercialization Workshop Series Commercialization Pathways April 2, 2015 Commercialization Workshop Series Commercialization Pathways Commercialization Options Parasight Seikowave Dean Harvey Eric Hauck
More informationDiagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs
Diagnostic assays based on molecular markers Discussion platform on patenting procedures - exchange with NPOs Programme Draft 10 11 May 2016 Warsaw, Poland In co-operation with: Venue Patent Office of
More informationPatent Purchase Information of Seller
Patent Purchase Information of Seller Seller submits the following information as of November 19, 2013. 1. Contact Information. Name of company/assignee Name of seller (if different) Key contact person
More informationMerriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box Wellesley, MA
Merriann M. Panarella, Esq. Panarella Dispute Resolution Services P.O. Box 812179 Wellesley, MA 02482 mpanarella@panarellaadr.com 508 653-2455 Dispute Resolution Services Dispute resolution services include
More informationBreakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC
Breakfast briefing: Ross DeVol Chief Research Officer Milken Institute September 22, 2011 The Phoenix Park Hotel Washington, DC Study overview Part 1: The Global Biomedical Industry: Understanding the
More informationStudy overview. The Global Biomedical Industry: Preserving U.S. Leadership
Presentation for: Voluntary Health Leadership Conference February 9, 2012 Rancho Bernardo Inn San Diego, CA Ross DeVol Chief Research Officer Milken Institute Study overview Part 1: Understanding the Factors
More informationGuidelines for Facilitating the Use of Research Tool Patents in the Life Sciences. March 1, 2007 Council for Science and Technology Policy
Guidelines for Facilitating the Use of Research Tool Patents in the Life Sciences March 1, 2007 Council for Science and Technology Policy 1. Introduction (1) In the domains of medicine and biotechnology,
More informationEL PASO COMMUNITY COLLEGE PROCEDURE
For information, contact Institutional Effectiveness: (915) 831-6740 EL PASO COMMUNITY COLLEGE PROCEDURE 2.03.06.10 Intellectual Property APPROVED: March 10, 1988 REVISED: May 3, 2013 Year of last review:
More informationCompliance for Eucomed: The Medical Technology Industry s s Perspective
Compliance for Eucomed: The Medical Technology Industry s s Perspective Rome, May 29, 2009 John Wilkinson Chief Executive - Eucomed Outline Overview of the Medical Technology Industry What is it? How big
More informationVTIP in 20 Minutes What You Need to Know
VTIP in 20 Minutes What You Need to Know Virginia Tech Intellectual Properties, Inc. VTIP Overview Virginia Tech Intellectual Properties, Inc. Not-for-profit, affiliated corporation of Virginia Tech Aligned
More informationSmith A. Brownlie III, CPA
Brownlie & Braden, LLC, provides services specifically addressing the needs of individuals and families that have accumulated significant wealth. Our approach to providing these services is sensitive to
More informationKey issues in building a strong life sciences patent portfolio. Tom Harding and Jane Wainwright Potter Clarkson LLP
Key issues in building a strong life sciences patent portfolio Tom Harding and Jane Wainwright Potter Clarkson LLP SECURING INNOVATION PATENTS TRADE MARKS DESIGNS Award winning, expert intellectual property
More informationPerspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond
Perspectives of Innovative Small Companies on the Industry s Prospects for 2012 and Beyond ACI Forum on Structuring, Negotiating and Managing Life Sciences Collaborations and Acquisitions February 28,
More informationState of Licensing 2011 Update
State of Licensing 2011 Update Moderators/Speakers Hemmie Chang, Chair, Licensing & Strategic Alliance Practice Group, Foley Hoag LLP Ranya Dajani, Executive Director, Strategic Transactions Group, Bristol-
More informationPROTECT Project. Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium
PROTECT Project Joanna Groves Chief Executive Officer 27 April 2010 EFPIA Patient Think-Tank Brussels, Belgium Content of Presentation About IAPO Overview of PROTECT Work Package 4 - New methods for data
More informationPATENT AND LICENSING POLICY SUMMARY
PATENT AND LICENSING POLICY SUMMARY Policy II-260 OBJECTIVE To define and outline the policy of the British Columbia Cancer Agency and the British Columbia Cancer Foundation concerning the development
More informationCeQur establishes Wales subsidiary
FOR IMMEDIATE RELEASE CeQur establishes Wales subsidiary -- Arthurian Life Sciences investment helps bring to market world s first three-day simple insulin infusion device for type 2 diabetes -- LUCERNE,
More informationALAN G. HEVESI, : Defendant. : DEPUTY CHIEF INVESTIGATOR GREGORY J. STASIUK of the Office of
NEW YORK CITY CRIMINAL COURT NEW YORK COUNTY - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - X THE PEOPLE OF THE STATE OF NEW YORK : -against- : ALAN G. HEVESI, : FELONY COMPLAINT
More informationINTELLECTUAL PROPERTY POLICY
INTELLECTUAL PROPERTY POLICY Overview The University of Texas System (UT System) Board of Regents (Board) and the University of Texas Health Science Center at San Antonio (Health Science Center) encourage
More informationTECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION
utrf@tennessee.com TECHNOLOGY TRANSFER AT THE UNIVERSITY OF TENNESSEE: INVENTIONS AND COMMERCIALIZATION Hot Topics in Research, May 23, 2017 Richard Magid, PhD UTRF Vice President WHAT IS TECHNOLOGY TRANSFER?
More informationPublic Art Network Best Practice Goals and Guidelines
Public Art Network Best Practice Goals and Guidelines The Public Art Network (PAN) Council of Americans for the Arts appreciates the need to identify best practice goals and guidelines for the field. The
More informationIP and Technology Management for Universities
IP and Technology Management for Universities Yumiko Hamano Senior Program Officer WIPO University Initiative Innovation and Technology Transfer Section, Patent Division, WIPO Outline! University and IP!
More informationConnecting People, Science and Regulation
Connecting People, Science and Regulation Bethesda Towers 4350 East West Highway Suite 600 Bethesda, MD 20814 USA Tel: +1 (301) 656-5900 Fax: +1 (301) 986-0296 www.pda.org PDA Europe ggmbh Am Borsigturm
More informationBaxter 2007 Investor Conference March 14, 2007
Joy A. Amundson is a corporate vice president of Baxter Healthcare Corporation and president of the company s BioScience business. In this position, she is responsible for the development and worldwide
More informationCommittee Member Employment Consultant Speaker s Bureau Ownership/ Partnership / Principal. Expert Witness
2013 ACCF/AHA/SCAI Clinical Competence Statement on Coronary Interventional Procedures (Revision of 2007 Statement) Online Author Listing of Comprehensive Relationships With Industry and Other Entities
More informationDiscovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.
Discovery: From Concept to the Patient - The Business of Medical Discovery Todd Sherer, Ph.D. Associate Vice President for Research and Director of OTT President Elect, Association of University Technology
More informationCelebrating International Women's Day Friday, March 8, :30am-1:00pm
Co-Hosted by: Join us in Launching the 1st Annual Successful Women of San Diego Executive Leadership Panel Celebrating International Women's Day Friday, March 8, 2019 11:30am-1:00pm Sponsored by: Location:
More informationWritten Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum
Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum List of recommendations: Recommendation 1: That the government creates a Life Sciences
More informationAchievements of FP7 examples that make us proud
Achievements of FP7 examples that make us proud Acknowledgements This booklet is a true, but humble, product of European cooperation, just like the inspiring examples it contains. All of the content was
More informationBayer Inc. Science for a Better Life. Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division
Bayer Inc. Science for a Better Life Talking with Phil Blake, President, Bayer Inc., HealthCare Representative and Head, Pharmaceuticals Division Please review your career path to date, leading to your
More informationFinancing Growth Ventures to Minimize Equity Dilution
Financing Growth Ventures to Minimize Equity Dilution An entrepreneurial team s mission is to develop and grow its venture and to optimize the management team s equity ownership stake. Significant growth
More informationSmith A. Brownlie III, CPA
Brownlie & Braden, LLC, provides services specifically addressing the needs of individuals and families that have accumulated significant wealth. Our approach to providing these services is sensitive to
More informationConvergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA
EUnetHTA European network for Health Technology Assessment Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA University of Tokyo, October 24,
More informationLife Sciences Queensland announces latest LSQ Ambassadors
MEDIA RELEASE Monday 22 April, 2013 FOR IMMEDIATE RELEASE Life Sciences Queensland announces latest LSQ Ambassadors (LSQ) is pleased to announce our latest LSQ Ambassadors - two of the life sciences industry
More informationFinn Børlum Kristensen, MD, PhD Director, EUnetHTA Secretariat Danish Health and Medicines Authority (EUnetHTA Coordinator) Copenhagen, Denmark
EUnetHTA European network for Health Technology Assessment DATABASES, REGISTRIES AND OTHER DATA CAPTURE TOOLS: HOW CAN WE AVOID MULTIPLICITY AND CREATE AN INTEGRATED DATA-CAPTURE APPROACH ALONG THE PRODUCT
More informationTHE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES
THE BUSINESS OF THE BRAIN 2.0 ACCELERATING PROGRESS TOWARD CURES Join us for a very special program co-hosted the HBS Alumni of Boston (HBSAB), The Harvard Stem Cell Institute (HSCI), and the Harvard NeuroDiscovery
More informationIssues in Emerging Health Technologies Bulletin Process
Issues in Emerging Health Technologies Bulletin Process Updated: April 2015 Version 1.0 REVISION HISTORY Periodically, this document will be revised as part of ongoing process improvement activities. The
More informationJean W. Frydman Partner
Jean W. Frydman Partner Princeton, NJ Tel: 609.895.6630 Fax: 609.896.1469 jfrydman@foxrothschild.com A former general counsel for multinational pharmaceutical companies and a multinational retail dietary
More informationRichard J. Donoghue Senior Vice President for Strategy, Planning and Business Development
Richard J. Donoghue Senior Vice President for Strategy, Planning and Business Development Richard (Rick) J. Donoghue, senior vice president for strategy, planning and business development at NYU Langone
More informationDRAFT. Cardiac Safety Research Consortium CSRC. Membership Committee Charter. 12September2018. Table of Contents
DRAFT Cardiac Safety Research Consortium CSRC Membership Committee Charter 12September2018 Table of Contents Purpose of the CSRC Membership Charter and CSRC Membership Committee Composition, Responsibilities
More informationLIGAND PHARMACEUTICALS INCORPORATED (Exact Name of Registrant as Specified in Its Charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More informationAuthors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade. Digital Patient Engagement. Insights for the Pharmaceutical Industry
Authors Heidi Gautschi Alexandre Raynaud Damien Vossion Michael Wade Digital Patient Engagement Insights for the Pharmaceutical Industry March 2018 2 DIGITAL PATIENT ENGAGEMENT: INSIGHTS FOR THE PHARMACEUTICAL
More informationManagement to Host Conference Call at 8:30 a.m. ET today
Aclaris Therapeutics Reports Second Quarter 2016 Financial Results August 11, 2016 7:01 AM ET Management to Host Conference Call at 8:30 a.m. ET today MALVERN, Pa., Aug. 11, 2016 (GLOBE NEWSWIRE) -- (NASDAQ:ACRS),
More informationClarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC
Curriculum Vitae Clarke B. Nelson, CPA, ABV, CFF, CGMA, MBA Senior Managing Director & Founder InFact Experts LLC cnelson@infact-experts.com Salt Lake City Office 175 South Main Street, Suite 630 Salt
More informationTeresa V. Pahl Partner
Teresa represents clients in all phases and aspects of their businesses. Teresa s expertise includes matters involving general corporate law, securities law and real property law. Teresa works with early-stage
More informationMartha M. Kendrick. Areas of Experience. Practice & Background
Martha M. Kendrick Partner mkendrick@akingump.com Washington, D.C. T +1 202.887.4215 F +1 202.887.4288 Education J.D., Georgetown University Law Center, 1985 M.A., Bowling Green State University B.A.,
More informationOphthalmic Business Council Connecting Academy and industry leaders for more than 20 years
Ophthalmic Business Council 2018 2019 Connecting Academy and industry leaders for more than 20 years Lead the conversation The Ophthalmic Business Council (OBC) is an excellent way for leaders in the ophthalmic
More informationIntellectual Property
Intellectual Property Johnson & Johnson believes that the protection of intellectual property (IP) is essential to rewarding innovation and promoting medical advances. We are committed: to raising awareness
More informationFirst Course Lobster Bisque Soup with Roasted Fennel. Bread Service Caramelized Onion Walnut Roll with Whipped Maple Brie
Innovation Wing National Museum of American History Smithsonian Institution April 14, 2016 DINNER MENU First Course Lobster Bisque Soup with Roasted Fennel Bread Service Caramelized Onion Walnut Roll with
More informationPatented Medicine Prices Review Board P M P R B GUIDELINES REFORM. 15 th Annual Market Access Summit. Douglas Clark Executive Director PMPRB
Patented Medicine Prices Review Board P M P R B GUIDELINES REFORM Douglas Clark Executive Director PMPRB 15 th Annual Market Access Summit Background Canada enacted a two-fold reform of its drug patent
More informationThe Global Alliance for Chronic diseases (GACD)
The Global Alliance for Chronic diseases (GACD) Global Health Policy Forum Brussels, 12 th June 2014 Karim Berkouk Deputy Head of the Medical Research Unit Health Directorate Research & Directorate General
More informationFood Science for the Non-Food Scientist Instructor Biographies
Food Science for the Non-Food Scientist Instructor Biographies Bob Baron is the Vice President of Business Development at Sensory Spectrum. In this role he works closely with clients to create tailored
More informationCalifornia State University, Northridge Policy Statement on Inventions and Patents
Approved by Research and Grants Committee April 20, 2001 Recommended for Adoption by Faculty Senate Executive Committee May 17, 2001 Revised to incorporate friendly amendments from Faculty Senate, September
More informationINTERNATIONAL WINTER SCHOOL
INTERNATIONAL WINTER SCHOOL RESEARCH PROMOTION, TECHNOLOGY TRANSFER AND BUSINESS CREATION November 22nd 2010, Alexandria, Egypt Anita COHEN Délégation à la Recherche Clinique et à l'innovation 80 rue Brochier
More informationScience - Industry Relationships in High-tech Sectors: Transatlantic Perspectives
Science - Industry Relationships in High-tech Sectors: Transatlantic Perspectives OECD / BMB+F Conference on Industry - Science Relationships Berlin, October 16-17th, 2000 no. 1 1. Empirical Basis Higher
More informationVirtual Clinical Trials: Challenges and Opportunities
Virtual Clinical Trials: Challenges and Opportunities November 28 29, 2018 National Academy of Sciences Building, Lecture Room 2101 Constitution Ave. NW, Washington, DC 20418 Background: The cost of bringing
More informationPATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY
PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY FUNDAMENTALS OF GLOBAL LAW, PRACTICE AND STRATEGY by PHILIP W. GRUBB European Patent Attorney CLARENDON PRESS OXFORD 1999 CONTENTS Preface to the
More informationAdditional information about Christopher Wootton is available on the SEC s Web site at
Christopher Wootton ChFC CRD #5428911 Common Wealth Centre 2040 North Loop 336W, Suite 125 Conroe, TX 77304 This Brochure Supplement provides information about Christopher Wootton that supplements the
More informationKeynote speakers 2017
Keynote speakers 2017 William B. Gartner Professor of Entrepreneurship and the Art of Innovation, Copenhagen Business School, Denmark and California Lutheran University, United States Keynote: All entrepreneurship
More informationReport OIE Animal Welfare Global Forum Supporting implementation of OIE Standards Paris, France, March 2018
Report OIE Animal Welfare Global Forum Supporting implementation of OIE Standards Paris, France, 28-29 March 2018 1. Background: In fulfilling its mandate to protect animal health and welfare, the OIE
More informationWe Work For Health Champions Awards Class of AstraZeneca: John McCarthy Vice President, Commercial Operations
We Work For Health Champions Awards Class of 2012 Brief Biographical Information (Alphabetical by Member Company) The We Work For Health Champion Awards are given annually to those to individuals who have
More informationIndustrial Investment in Research and Development: Trends and Prospects
MEMO/05/471 Brussels, 9 December 2005 Industrial Investment in Research and Development: Trends and Prospects The 2005 Key Figures for science, technology and innovation released last July showed EU R&D
More informationEU Livestock subsidies' effect on red meat consumption
EU Livestock subsidies' effect on red meat consumption Nutrition, Physical Activity & Cancer Prevention: Current Challenges, New Horizons September 13, 2010 EPHAC (conflicts of interest) Brussels based
More informationTo the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018
To the shareholders of Nordic Nanovector ASA Oslo, 8 May 2018 RECOMMENDATION OF THE NOMINATION COMMITTEE 1. INTRODUCTION The Nomination Committee of Nordic Nanovector ASA comprises of Johan Christenson
More informationAcademic Technology Licensing & the America Invents Act
Academic Technology Licensing & the America Invents Act Eric Gosink, Ph.D. Senior Licensing Officer November 1 st, 2013 University of California San Diego Expertise and Resources Scripps Inst. Oceanography,
More informationSecond medical use claims The pregabalin litigation in Europe IMK seminar at Awapatent, 18 May 2017
Second medical use claims The pregabalin litigation in Europe IMK seminar at Awapatent, 18 May 2017 Niklas Mattsson MSc Mol Biotech Engineering European Patent Attorney niklas.mattsson@awapatent.com Outline
More informationLISA ROTH MONAHAN & ROTH, LLC 630 FIRST AVENUE SAN DIEGO, CA 92101
LISA ROTH MONAHAN & ROTH, LLC 630 FIRST AVENUE SAN DIEGO, CA 92101 BACKGROUND Lisa Roth is the of Monahan & Roth, LLC, a regulatory compliance company providing services including professional consultations,
More informationLoyola University Maryland Provisional Policies and Procedures for Intellectual Property, Copyrights, and Patents
Loyola University Maryland Provisional Policies and Procedures for Intellectual Property, Copyrights, and Patents Approved by Loyola Conference on May 2, 2006 Introduction In the course of fulfilling the
More information2008 HSC Notes from the Marking Centre Food Technology
2008 HSC Notes from the Marking Centre Food Technology 2009 Copyright Board of Studies NSW for and on behalf of the Crown in right of the State of New South Wales. This document contains Material prepared
More informationShareholders are invited to the 2018 Annual Meeting which is scheduled for 27 September 2018.
7 September 2018 Dear Shareholder 2018 Annual Meeting of Shareholders Shareholders are invited to the 2018 Annual Meeting which is scheduled for 27 September 2018. The details of the Annual Meeting are
More informationTHE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION)
THE CORPORATE REPUTATION OF PHARMA THE PATIENT PERSPECTIVE IN 2015 (EASTERN-EUROPE EDITION) Feedback from 93 Eastern-European patient groups PUBLISHED JULY 2016 CONTENTS ABOUT THIS REPORT Page 1 WHAT DID
More information2016 ICGN Annual General Meeting
Item 14, June ICGN Board Meeting 2016 ICGN Annual General Meeting Composition of the Nomination Committee Erik Breen, Chair, ICGN Board of Governors The ICGN Nomination Committee is constituted in accordance
More informationHow To Draft Patents For Future Portfolio Growth
For the latest breaking news and analysis on intellectual property legal issues, visit Law today. www.law.com/ip Portfolio Media. Inc. 860 Broadway, 6th Floor New York, NY 10003 www.law.com Phone: +1 646
More informationSize of California s economy US$ trillions, 2009
Size of California s economy US$ trillions, 2009 Rank Country Gross domestic product 1 United States 14 2 Japan 5.1 3 China 4.9 4 Germany 3.3 5 France 2.6 6 United Kingdom 2.2 7 44 Italy 2.1 8 California
More informationSouth-South Exchange Meeting on the Conservation and Sustainable Use of Forest Biodiversity, 8-10 July 2009
South-South Exchange Meeting on the Conservation and Sustainable Use of Forest Biodiversity, 8-10 July 2009 ACCESS TO GENETIC RESOURCES AND BENEFIT-SHARING Valérie Normand Secretariat of the Convention
More informationSofosbuvir Patent Oppositions at European Patent Office
Challenging patent system in High Income Countries Sofosbuvir Patent Oppositions at European Patent Office Olivier Maguet Médecins du Monde, Drug Pricing Campaign WHS 2017, Sao Paulo, Options for countries
More informationHTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:
HTA Position Paper The Global Medical Technology Alliance (GMTA) represents medical technology associations whose members supply over 85 percent of the medical devices and diagnostics purchased annually
More information150th Annual General Meeting of Nestlé S.A. Lausanne, 6 April Speeches. Peter Brabeck-Letmathe Chairman of the Board
150th Annual General Meeting of Nestlé S.A. Lausanne, 6 April 2017 Speeches Peter Brabeck-Letmathe Chairman of the Board Ulf Mark Schneider Chief Executive Officer Disclaimer This speech might not reflect
More informationPROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS
PRESS RELEASE FOR IMMEDIATE RELEASE PROMETIC REPORTS 2017 THIRD QUARTER HIGHLIGHTS AND FINANCIAL RESULTS US $80 million (CAD $100 million) line of credit secured from Structured Alpha LP Plasminogen BLA
More informationThe 2011 EU industrial R&D investment SCOREBOARD
1 The 2011 EU industrial R&D investment SCOREBOARD Joint Research Centre European Commission Héctor Hernández Alex Tuebke Fernando Hervás 1. Background 2 Understanding the dynamics of industrial R&D at
More informationWIPO NATIONAL WORKSHOP FOR PATENT LAWYERS
ORIGINAL: English DATE: May 1997 GOVERNMENT OF THE FEDERAL DEMOCRATIC REPUBLIC OF ETHIOPIA WORLD INTELLECTUAL PROPERTY ORGANIZATION WIPO NATIONAL WORKSHOP FOR PATENT LAWYERS organized by the World Intellectual
More informationEligibility Criteria Created Sunday, November 09, 2014
Eligibility Criteria Created Sunday, November 09, 2014 Please review each eligibility criteria below. Please check the box if you are in compliance with each criteria. Ineligible applicants will not be
More informationINTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima
INTELLECTUAL PROPERTY OVERVIEW Patrícia Lima October 14 th, 2015 Intellectual Property INDUSTRIAL PROPERTY (INPI) COPYRIGHT (IGAC) It protects technical and aesthetical creations, and trade distinctive
More informationMeeting of the EDEN HEALTH DISTRICT BOARD OF DIRECTORS OPEN SESSION January 16, 2019 Eden Health District - Conference Room. 5:30 p.m.
Meeting of the EDEN HEALTH DISTRICT BOARD OF DIRECTORS OPEN SESSION - Conference Room. 5:30 p.m. APPROVED I. CALL TO ORDER Chair Galvan called the meeting to order at 5:30 p.m. Directors Present: Staff
More information[Definitions of terms that are underlined are found at the end of this document.]
Policy Direction - Pharmaceutical Industry Relationships [Definitions of terms that are underlined are found at the end of this document.] Rationale and Relationship to Mission, Principles and Values The
More informationTransferring UCLA discoveries to the public. Kathryn Atchison, DDS, MPH Vice Provost, Associate Vice Chancellor for Research
Transferring UCLA discoveries to the public. Kathryn Atchison, DDS, MPH Vice Provost, Associate Vice Chancellor for Research UCLA Research: A Winning Environment $811M+ in research awards for FY2006 3,300
More informationTHE EUROPEAN COUNCIL OF ACADEMIES OF APPLIED SCIENCES, TECHNOLOGIES AND ENGINEERING
THE EUROPEAN COUNCIL OF ACADEMIES OF APPLIED SCIENCES, TECHNOLOGIES AND ENGINEERING Presentation to the CAETS Council Meeting Beijing, June 4, 2014 Jacques Lukasik, Euro-CASE Secretary General Fellow of
More informationImplementation of Systems Medicine across Europe
THE CASyM ROADMAP Implementation of Systems Medicine across Europe A short roadmap guide 0 The road toward Systems Medicine A new paradigm for medical research and practice There has been a data generation
More informationDCRI COMMERCIAL RELATIONSHIPS TRACKING FORM
DCRI COMMERCIAL RELATIONSHIPS TRACKING FORM COI Reporting is based on the previous year and anticipated relationships for the coming year. Please report current and anticipated information for the calendar
More informationSPONSORED BY WORLD GOLD TRUST SERVICES, LLC
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event
More information